Synapse - Works

Results (2434)

High disease-free survival and enhanced protection against relapse after double-unit cord blood transplantation (DCB-T) when compared to unrelated donor transplantation (URD-T) in patients with acute leukemia, MDS and CML

Meeting Abstract

Ponce, D. M.; Devlin, S.; Lubin, M.; Maloy, M.; Castro-Malaspina, H.; Goldberg, J. D.; Jakubowski, A. A.; Papadopoulos, E.; Perales, M. A.; Sauter, C.; more...
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Retrospective study of 240 patients with severe combined immunodeficiency transplanted from 2000-2009: A report from the primary immune deficiency treatment consortium of North America

Meeting Abstract

Pai, S. Y.; Logan, B. R.; Griffith, L. M.; Buckley, R. H.; Parrott, R. E.; Dvorak, C. C.; Kapoor, N.; Hanson, I. C.; Filipovich, A.; Jyonouchi, S.; more...
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Intrathecal chemotherapy post hematopoietic cell transplantation for prevention of central nervous system relapse in pediatric acute leukemia

Meeting Abstract

Mitchell, R.; Shah, N.; Lehrman, R.; Kobos, R.; Scaradavou, A.; Boulad, F.; Kernan, N.; O'reilly, R.; Prockop, S. E.
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

IL-22 administration protects intestinal stem cells from GVHD

Meeting Abstract

Lindemans, C.; Mertelsmann, A.; Dudakov, J. A.; Velardi, E.; Hua, G. Q.; O'connor, M.; Kolesnick, R.; van den Brink, M. R. M.; Hanash, A. M.
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

T cells expressing cars directed against HLA-0201-Rmf WT-1 peptide complex can effectively eradicate WT1+A0201+ tumor cells in-vitro

Meeting Abstract

Kuo, T. Y.; Hasan, A. N.; Zhao, Q.; Selvakumar, A.; Tassev, D.; Cheung, N. K.; O'reilly, R.
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Identification of intestinal commensal bacteria protective against GVHD in mice and humans

Meeting Abstract

Jenq, R.; van den Brink, M. R. M.
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Do patients with high risk or relapsed core binding factor acute myeloid leukemia benefit from salvage allogeneic stem cell transplantation?

Meeting Abstract

Hobbs, G.; Kishtagari, A.; Hilden, P.; Barker, J. N.; Jakubowski, A. A.; Papadopoulos, E.; Devlin, S.; Boulad, F.; Kernan, N.; Kobos, R.; more...
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Generation and characterization of a third party GMP grade bank of CMV specific T-cells for adoptive immunotherapy of CMV infections in recipients of HSCT from cord blood or seronegative donors

Meeting Abstract

Hasan, A. N.; Doubrovina, E. S.; Koehne, G.; Prockop, S. E.; O'reilly, R.
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Busulfan, melphalan, and thiotepa conditioning for allogeneic hematopoietic stem cell transplantation (HSCT) of pediatric patients with acute leukemia and central nervous system (CNS) disease

Meeting Abstract

Forlenza, C. J.; Kobos, R.; Kernan, N. A.; Scaradavou, A.; Prockop, S. E.; Curran, K.; Shukla, N.; Steinherz, P. G.; O'reilly, R.; Boulad, F.
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Allogeneic hematopoietic stem cell transplantation (HSCT) for non malignant hematologic disorders (NMHD), using a chemotherapy-only cytoreductive regimen and T-cell depleted grafts from alternative donors

Meeting Abstract

Boulad, F.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; Lehrman, R.; Ruggiero, J. M.; Curran, K.; Kobos, R.; O'reilly, R.
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save